Jun 28, 2019
Just Biotherapeutics and Teva Enter an Agreement for the Design and Development of a High Productivity (HP) Biomanufacturing Process
Jun 25, 2019
Avista Capital Partners To Sell Trimb To Karo Pharma
Jun 24, 2019
Active Pharmaceutical Ingredients (API) Market to Exceed US$257.5 Billion by 2026, Says TMR
Jun 13, 2019
Global Asthma Therapeutics Market to Surpass US$ 20.4 Billion by 2026 - Coherent Market Insights
May 31, 2019
Global Pharma, Biotech and Diagnostics Distribution Partnering Directory 2019: Company A-Z, Headline Value, Stage of Development at Signing, Therapeutic Area, & Technology Type
May 22, 2019
Consumers Around the Country Turn to Over the Counter Drugs for Relief
May 16, 2019
Lannett Begins Marketing Generic Adderall®
May 09, 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
May 02, 2019
Global Erectile Dysfunction (ED) Drugs Market to 2023 with Bayer, Eli Lilly and Co, Pfizer, Teva Pharma, & Vivus Dominating
Apr 24, 2019
Global $200+ Billion Drug API Market Forecasts to 2024 with Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma and Cipla Dominating
Apr 17, 2019
Biotech Brief: Optimism Rising for Cancer Treatment Advancements in 2019
Apr 11, 2019
Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market
Apr 10, 2019
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST 2019-2027
Apr 10, 2019
Global Central Nervous System Therapeutic Market Report 2014-2024 Featuring Biogen, Pfizer, Teva, Novartis, J & J, Shire, Merck & Co, AstraZeneca, Otsuka, & Eli Lilly
Mar 29, 2019
District Court of Delaware Rules that Actavis does not Infringe with their Suboxone® and Subutex® Generics
Mar 25, 2019
Spherix Global Insights' Quarterly Update on the US Migraine Prevention Market Reveals Best-In-Class Sales and Medical Affairs Support as the Driving Force Behind Teva's Ajovy Early Launch Success
Mar 21, 2019
Teva Selects Genedata Biologics to Support Next-generation Biopharmaceuticals R&D
Feb 21, 2019
Trimb Enters into Exclusive Licensing Agreement with Teva for Flux, Decubal and Other Brands
Feb 19, 2019
United States Generic Drug Markets, 2011-2018 & 2019-2024 - Patent Expiry of Blockbuster Drugs & Significant Price Differential between Generics and Innovator Drugs
Feb 14, 2019
Global $273 Bn Active Pharmaceutical Ingredient Market to 2026 Featuring TEVA Pharma & Dr. Reddys